スタッフ紹介
田中 正剛 業績集
原著論文
M. Tanaka and Y. Iwakiri: Lymphatics in the liver. Curr Opin Immunol 53:137-142, 2018.
J. Saruwatari, C. Dong, T. Utsumi, M. Tanaka, M. McConnell and Y. Iwakiri: Integrated analysis of microRNA and mRNA expression profiles in splenomegaly induced by non-cirrhotic portal hypertension in rats. Sci Rep 8(1):17983, 2018.
M. Tanaka and Y. Iwakiri: The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis. Cell Mol Gastroenterol Hepatol 2(6):733-749, 2016.
M. Tanaka, K. Tanaka, Y. Masaki, M. Miyazaki, M. Kato, K. Kotoh, M. Enjoji, M. Nakamuta and R. Takayanagi: Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats. Int J Mol Med 33(2):254-62, 2014.
K. Tanaka, Y. Masaki, M. Tanaka, M. Miyazaki, M. Enjoji, M. Nakamuta, M. Kato, M. Nomura, T. Inoguchi, K. Kotoh and R. Takayanagi: Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats. World J Gastroenterol 20(10):2653-63, 2014.
M. Tanaka, Y. Masaki, K. Tanaka, M. Miyazaki, M. Kato, R. Sugimoto, K. Nakamura, S. Aishima, K. Shirabe, M. Nakamuta, M. Enjoji, K. Kotoh and R. Takayanagi: Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC. Mol Med Rep 7(2):365-70, 2013.
S. Takao, K. Tanaka, M. Miyazaki, M. Tanaka, T. Ohashi, M. Kato, K. Kotoh, S. Aishima and R. Takayanagi: A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible? Clin J Gastroenterol 6(5):386-9, 2013.
M. Miyazaki, M. Kato, M. Tanaka, K. Tanaka, S. Takao, M. Kohjima, T. Ito, M. Enjoji, M. Nakamuta, K. Kotoh and R. Takayanagi: Antithrombin III injection via the portal vein suppresses liver damage. World J Gastroenterol 18(16):1884-91, 2012.
M. Miyazaki, M. Kato, K. Tanaka, M. Tanaka, M. Kohjima, K. Nakamura, M. Enjoji, M. Nakamuta, K. Kotoh and R. Takayanagi: Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. Mol Med Rep 5(3):729-33, 2012.
M. Miyazaki, M. Tanaka, A. Ueda, T. Yoshimoto, M. Kato, M. Nakamuta, K. Kotoh and R. Takayanagi: Acute liver failure caused by drug-induced hypersensitivity syndrome associated with hyperferritinemia. World J Gastroenterol 17(44):4928-31, 2011.
M. Miyazaki, M. Kato, M. Tanaka, K. Tanaka, S. Takao, M. Kohjima, T. Ito, M. Enjoji, M. Nakamuta, K. Kotoh and R. Takayanagi: Contrast-enhanced ultrasonography using Sonazoid to evaluate changes in hepatic hemodynamics in acute liver injury. J Gastroenterol Hepatol 26(12):1749-56, 2011.
K. Kotoh, M. Kato, M. Kohjima, M. Tanaka, M. Miyazaki, K. Nakamura, M. Enjoji, M. Nakamuta and R. Takayanagi: Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure. Exp Ther Med 2(2):195-199, 2011.
N. Higuchi, M. Kato, M. Tanaka, M. Miyazaki, S. Takao, M. Kohjima, K. Kotoh, M. Enjoji, M. Nakamuta and R. Takayanagi: Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease. Exp Ther Med 2(6):1077-1081, 2011.
N. Higuchi, M. Kato, M. Miyazaki, M. Tanaka, M. Kohjima, T. Ito, M. Nakamuta, M. Enjoji, K. Kotoh and R. Takayanagi: Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver. J Cell Biochem 112(1):30-8, 2011.
M. Nakamuta, R. Yada, T. Fujino, M. Yada, N. Higuchi, M. Tanaka, M. Miyazaki, M. Kohjima, M. Kato, T. Yoshimoto, N. Harada, A. Taketomi, Y. Maehara, M. Koga, T. Nishinakagawa, M. Nakashima, K. Kotoh and M. Enjoji: Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy? Int J Mol Med 24(6):825-8, 2009.
K. Kotoh, A. Ueda, M. Tanaka, M. Miyazaki, M. Kato, M. Kohjima, M. Enjoji, M. Nakamuta and R. Takayanagi: A high prevalence of extreme hyperferritinemia in acute hepatitis patients. Hepat Med 1:1-8, 2009.
N. Higuchi, M. Kato, Y. Shundo, H. Tajiri, M. Tanaka, N. Yamashita, M. Kohjima, K. Kotoh, M. Nakamuta, R. Takayanagi and M. Enjoji: Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res 38(11):1122-9, 2008.
J. Saruwatari, C. Dong, T. Utsumi, M. Tanaka, M. McConnell and Y. Iwakiri: Integrated analysis of microRNA and mRNA expression profiles in splenomegaly induced by non-cirrhotic portal hypertension in rats. Sci Rep 8(1):17983, 2018.
M. Tanaka and Y. Iwakiri: The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis. Cell Mol Gastroenterol Hepatol 2(6):733-749, 2016.
M. Tanaka, K. Tanaka, Y. Masaki, M. Miyazaki, M. Kato, K. Kotoh, M. Enjoji, M. Nakamuta and R. Takayanagi: Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats. Int J Mol Med 33(2):254-62, 2014.
K. Tanaka, Y. Masaki, M. Tanaka, M. Miyazaki, M. Enjoji, M. Nakamuta, M. Kato, M. Nomura, T. Inoguchi, K. Kotoh and R. Takayanagi: Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats. World J Gastroenterol 20(10):2653-63, 2014.
M. Tanaka, Y. Masaki, K. Tanaka, M. Miyazaki, M. Kato, R. Sugimoto, K. Nakamura, S. Aishima, K. Shirabe, M. Nakamuta, M. Enjoji, K. Kotoh and R. Takayanagi: Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC. Mol Med Rep 7(2):365-70, 2013.
S. Takao, K. Tanaka, M. Miyazaki, M. Tanaka, T. Ohashi, M. Kato, K. Kotoh, S. Aishima and R. Takayanagi: A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible? Clin J Gastroenterol 6(5):386-9, 2013.
M. Miyazaki, M. Kato, M. Tanaka, K. Tanaka, S. Takao, M. Kohjima, T. Ito, M. Enjoji, M. Nakamuta, K. Kotoh and R. Takayanagi: Antithrombin III injection via the portal vein suppresses liver damage. World J Gastroenterol 18(16):1884-91, 2012.
M. Miyazaki, M. Kato, K. Tanaka, M. Tanaka, M. Kohjima, K. Nakamura, M. Enjoji, M. Nakamuta, K. Kotoh and R. Takayanagi: Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. Mol Med Rep 5(3):729-33, 2012.
M. Miyazaki, M. Tanaka, A. Ueda, T. Yoshimoto, M. Kato, M. Nakamuta, K. Kotoh and R. Takayanagi: Acute liver failure caused by drug-induced hypersensitivity syndrome associated with hyperferritinemia. World J Gastroenterol 17(44):4928-31, 2011.
M. Miyazaki, M. Kato, M. Tanaka, K. Tanaka, S. Takao, M. Kohjima, T. Ito, M. Enjoji, M. Nakamuta, K. Kotoh and R. Takayanagi: Contrast-enhanced ultrasonography using Sonazoid to evaluate changes in hepatic hemodynamics in acute liver injury. J Gastroenterol Hepatol 26(12):1749-56, 2011.
K. Kotoh, M. Kato, M. Kohjima, M. Tanaka, M. Miyazaki, K. Nakamura, M. Enjoji, M. Nakamuta and R. Takayanagi: Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure. Exp Ther Med 2(2):195-199, 2011.
N. Higuchi, M. Kato, M. Tanaka, M. Miyazaki, S. Takao, M. Kohjima, K. Kotoh, M. Enjoji, M. Nakamuta and R. Takayanagi: Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease. Exp Ther Med 2(6):1077-1081, 2011.
N. Higuchi, M. Kato, M. Miyazaki, M. Tanaka, M. Kohjima, T. Ito, M. Nakamuta, M. Enjoji, K. Kotoh and R. Takayanagi: Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver. J Cell Biochem 112(1):30-8, 2011.
M. Nakamuta, R. Yada, T. Fujino, M. Yada, N. Higuchi, M. Tanaka, M. Miyazaki, M. Kohjima, M. Kato, T. Yoshimoto, N. Harada, A. Taketomi, Y. Maehara, M. Koga, T. Nishinakagawa, M. Nakashima, K. Kotoh and M. Enjoji: Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy? Int J Mol Med 24(6):825-8, 2009.
K. Kotoh, A. Ueda, M. Tanaka, M. Miyazaki, M. Kato, M. Kohjima, M. Enjoji, M. Nakamuta and R. Takayanagi: A high prevalence of extreme hyperferritinemia in acute hepatitis patients. Hepat Med 1:1-8, 2009.
N. Higuchi, M. Kato, Y. Shundo, H. Tajiri, M. Tanaka, N. Yamashita, M. Kohjima, K. Kotoh, M. Nakamuta, R. Takayanagi and M. Enjoji: Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res 38(11):1122-9, 2008.
- スタッフ紹介
- スタッフ紹介
